Click for best price
Hepatitis C Virus HCV Antiviral Market Size, Share 2022
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
This report contains market size and forecasts of Hepatitis C Virus (HCV) Antiviral in Global, including the following market information:
Global Hepatitis C Virus (HCV) Antiviral Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis C Virus (HCV) Antiviral market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HCV Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis C Virus (HCV) Antiviral include Roche Diagnostics, Abbott, Siemens, Qiagen, bioM?rieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics and Biogate Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis C Virus (HCV) Antiviral companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Virus (HCV) Antiviral Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, by Type, 2021 (%)
HCV Antibody
HCV Viral Load
HCV Genotyping
Global Hepatitis C Virus (HCV) Antiviral Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, by Application, 2021 (%)
Diagnostic Centers
Hospitals
Home Use
Global Hepatitis C Virus (HCV) Antiviral Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis C Virus (HCV) Antiviral revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis C Virus (HCV) Antiviral revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott
Siemens
Qiagen
bioM?rieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
| Report Attributes |
Report Details |
| Report Title |
Hepatitis C Virus (HCV) Antiviral Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis C Virus (HCV) Antiviral Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis C Virus (HCV) Antiviral Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Virus (HCV) Antiviral Overall Market Size
2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size: 2021 VS 2028
2.2 Global Hepatitis C Virus (HCV) Antiviral Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis C Virus (HCV) Antiviral Players in Global Market
3.2 Top Global Hepatitis C Virus (HCV) Antiviral Companies Ranked by Revenue
3.3 Global Hepatitis C Virus (HCV) Antiviral Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis C Virus (HCV) Antiviral Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis C Virus (HCV) Antiviral Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis C Virus (HCV) Antiviral Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis C Virus (HCV) Antiviral Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis C Virus (HCV) Antiviral Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis C Virus (HCV) Antiviral Market Size Markets, 2021 & 2028
4.1.2 HCV Antibody
4.1.3 HCV Viral Load
4.1.4 HCV Genotyping
4.2 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
4.2.1 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis C Virus (HCV) Antiviral Market Size, 2021 & 2028
5.1.2 Diagnostic Centers
5.1.3 Hospitals
5.1.4 Home Use
5.2 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
5.2.1 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis C Virus (HCV) Antiviral Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
6.2.1 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028
6.3.2 US Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.3.3 Canada Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.3.4 Mexico Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028
6.4.2 Germany Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.3 France Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.4 U.K. Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.5 Italy Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.6 Russia Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.4.8 Benelux Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028
6.5.2 China Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.5.3 Japan Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.5.4 South Korea Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.5.6 India Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028
6.6.2 Brazil Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.6.3 Argentina Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028
6.7.2 Turkey Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.7.3 Israel Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
6.7.5 UAE Hepatitis C Virus (HCV) Antiviral Market Size, 2017-2028
7 Players Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Corporate Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.1.4 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.1.5 Roche Diagnostics Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.2.4 Abbott Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.2.5 Abbott Key News
7.3 Siemens
7.3.1 Siemens Corporate Summary
7.3.2 Siemens Business Overview
7.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.3.4 Siemens Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.3.5 Siemens Key News
7.4 Qiagen
7.4.1 Qiagen Corporate Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.4.4 Qiagen Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.4.5 Qiagen Key News
7.5 bioM?rieux
7.5.1 bioM?rieux Corporate Summary
7.5.2 bioM?rieux Business Overview
7.5.3 bioM?rieux Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.5.4 bioM?rieux Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.5.5 bioM?rieux Key News
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Corporate Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.6.4 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.6.5 Bio-Rad Laboratories Key News
7.7 Meridian Bioscience
7.7.1 Meridian Bioscience Corporate Summary
7.7.2 Meridian Bioscience Business Overview
7.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.7.4 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.7.5 Meridian Bioscience Key News
7.8 Vista Diagnostics
7.8.1 Vista Diagnostics Corporate Summary
7.8.2 Vista Diagnostics Business Overview
7.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.8.4 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.8.5 Vista Diagnostics Key News
7.9 Biogate Laboratories
7.9.1 Biogate Laboratories Corporate Summary
7.9.2 Biogate Laboratories Business Overview
7.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.9.4 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.9.5 Biogate Laboratories Key News
7.10 J.Mitra & Co. Ltd
7.10.1 J.Mitra & Co. Ltd Corporate Summary
7.10.2 J.Mitra & Co. Ltd Business Overview
7.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.10.4 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.10.5 J.Mitra & Co. Ltd Key News
7.11 Siemens Medical
7.11.1 Siemens Medical Corporate Summary
7.11.2 Siemens Medical Business Overview
7.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.11.4 Siemens Medical Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.11.5 Siemens Medical Key News
7.12 General Biologicals
7.12.1 General Biologicals Corporate Summary
7.12.2 General Biologicals Business Overview
7.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Major Product Offerings
7.12.4 General Biologicals Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2017-2022)
7.12.5 General Biologicals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis C Virus (HCV) Antiviral Market Opportunities & Trends in Global Market
Table 2. Hepatitis C Virus (HCV) Antiviral Market Drivers in Global Market
Table 3. Hepatitis C Virus (HCV) Antiviral Market Restraints in Global Market
Table 4. Key Players of Hepatitis C Virus (HCV) Antiviral in Global Market
Table 5. Top Hepatitis C Virus (HCV) Antiviral Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis C Virus (HCV) Antiviral Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis C Virus (HCV) Antiviral Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis C Virus (HCV) Antiviral Product Type
Table 9. List of Global Tier 1 Hepatitis C Virus (HCV) Antiviral Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis C Virus (HCV) Antiviral Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis C Virus (HCV) Antiviral Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis C Virus (HCV) Antiviral Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis C Virus (HCV) Antiviral Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis C Virus (HCV) Antiviral Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2023-2028
Table 30. Roche Diagnostics Corporate Summary
Table 31. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 32. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 35. Abbott Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 36. Siemens Corporate Summary
Table 37. Siemens Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 38. Siemens Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 39. Qiagen Corporate Summary
Table 40. Qiagen Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 41. Qiagen Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 42. bioM?rieux Corporate Summary
Table 43. bioM?rieux Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 44. bioM?rieux Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Rad Laboratories Corporate Summary
Table 46. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 47. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 48. Meridian Bioscience Corporate Summary
Table 49. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 50. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 51. Vista Diagnostics Corporate Summary
Table 52. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 53. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 54. Biogate Laboratories Corporate Summary
Table 55. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 56. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 57. J.Mitra & Co. Ltd Corporate Summary
Table 58. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 59. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 60. Siemens Medical Corporate Summary
Table 61. Siemens Medical Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 62. Siemens Medical Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
Table 63. General Biologicals Corporate Summary
Table 64. General Biologicals Hepatitis C Virus (HCV) Antiviral Product Offerings
Table 65. General Biologicals Hepatitis C Virus (HCV) Antiviral Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis C Virus (HCV) Antiviral Segment by Type in 2021
Figure 2. Hepatitis C Virus (HCV) Antiviral Segment by Application in 2021
Figure 3. Global Hepatitis C Virus (HCV) Antiviral Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis C Virus (HCV) Antiviral Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis C Virus (HCV) Antiviral Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2021
Figure 8. By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 12. US Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 24. China Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis C Virus (HCV) Antiviral Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Siemens Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Qiagen Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. bioM?rieux Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Siemens Medical Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. General Biologicals Hepatitis C Virus (HCV) Antiviral Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
